>> What are the AI in bowel cancer care trials telling us?
>> How, when and why to add AI into the clinical pathway?
>> Who is making headway in unburdening ICSs from legacy health systems and fully embracing intelligent health initiatives?
In collaboration with our Innovation Partners, we've co-curated a programme that dives into the hottest topics in AI and healthcare with top clinicians, technologists, and heads of healthcare who are making breakthroughs to solve some of the world’s biggest challenges in healthcare.
Curiosity sits around whether an AI tech platform designed to assist in the detection of abnormalities within the colon will be a breakthrough in evaluating the effectiveness of AI in the FIRST UK clinical trial. Alexander Seager, Gastrointestinal Research Fellow, South Tyneside and Sunderland NHS Foundation Trust talks about transforming bowel cancer care through AI as one of the leading Researchers for the AI trial ‘COLO-DETECT’ underway at 9 NHS trusts.
Chelsea and Westminster Hospital NHS Foundation Trust is rolling out a pilot involving an AI decision support tool which aims to change the way skin cancer is assessed and treated by the NHS. This unmissable feature at Intelligent Health UK brings you the strategic, clinical and deployment leads that steered the DERM pilot in secondary care, DERM uses AI algorithms to analyse specialist magnified images of skin lesions so that patients can be assessed quickly and receive life-saving treatment promptly if required. Find out the exact challenges shared from a clinical perspective, the strategic decision making process, implementation timelines, processes and glitches with ‘must have’ pointers on adoption of AI in skincare at scale and tips on what to avoid with guest speaker Marcela Vizcaychipi, Deputy Chief Clinical Information Officer, Chelsea & Westminster Hospital.
A proactive NHS – a myth or new mindset we need to adopt? Is this moonshot finally in line of sight? Unburdening ICSs from legacy health systems and fully embracing intelligent health initiatives that have already become embedded across multiple Trusts has meant the discussion is steering away from ‘if’ to ‘how?’ and fast. A group of experts are set to steer the discussion on the ‘how’ behind converging clinical systems, sharing and accessing central data warehouses, building business intelligence platforms, and utilising data science resource effectively. Moving from the ‘in theory’ to the ‘what do you do with the collected data?’ and ‘how do you feed it back to the individual?’ to the genomics and preventative plans, all the hard and real questions get answered by Lee Rickles, CIO, Programme Director & Deputy SIRO, Humber Teaching NHS FT; Tamara Everington, Haematology Consultant and Chief Clinical Information Officer, Hampshire Hospitals NHS Foundation Trust; Robert Smillie, Chief Medical Information Officer, Royal Free London NHS Foundation Trust; Sigal Hachlili Dwyer, Director of AI, Data & Digital Innovation, Guy's and St Thomas' NHS Foundation Trust and Martin Gossling, Head of Commercial Innovation, University Hospital Southampton NHS Foundation Trust.
Mixed approaches cloud judgement around what the best way is to set up an AI working group into the clinical pathway. Amrita Kumar, Consultant Radiologist and Clinical Lead AI, Frimley Health NHS Foundation Trust; Rhodri Davies, Senior Clinical Fellow, University College London; Basab Bhattacharya, AI Lead and Consultant Radiologist, Barking, Havering and Redbridge University Hospitals NHS Trust and Ana Ribeiro, AI Transformation Lead, The Royal Marsden NHS Foundation Trust will debate live on stage on the importance of creating a comprehensive plan for how, when, and why to add AI into the clinical pathway, and how to carefully monitor the short-term and long-term impacts of doing so. What are the highest-ranked functionalities for an AI-enhanced care pathway? Once we decide to implement AI into the clinical pathway, where will the financial liability lie, with the NHS or ICS? How will it be done, how much, and in what capacity? Participate in the debate
Marc Farr, Chief Analytical Officer, East Kent Hospitals University NHS Foundation to give keynote talk on Trust Reimagining & Accelerating Health Equity, Access & Diversity
‘Providing local health systems with a better understanding of the population health issues driving health inequalities is essential to help NHS executives decide how best to plan and manage resources in collaboration with local authorities, as well as where to focus funding on prevention’ – says HSJ. They further suggest that ‘on the supplier side, analytics and data companies with a desire to help eliminate health inequalities must do three things: They must eliminate structural bias in data, they have to find the missing data that hides the inequalities from sight, and they have to ensure that the analytical teams have the ability to communicate clearly where in amongst data about overall improvement in population health, people are being left behind.’
Kiran Patel, Chief Medical Officer, Deputy CEO and Consultant Cardiologist, University Hospitals Coventry and Warwickshire NHS Trust takes the stage to discuss use of health data to reduce inequalities and improve patient and population care
Global AI and health events calendar 2023
Intelligent Health UK
24-25 May 2023
Platinum Suite, ExCeL London, UK
13-14 September 2023
Share your content with the Intelligent Health community
Got some interesting content you want to share with our community of over 220,000 AI and health Brains? You can send us anything from a published piece you have written online, white paper, article or interview. Submit it here